D21 - Pharmacy in Great Britain


Organised by the Local Host Committee


Great Britain is the home of some of the most advanced innovations in pharmacy, from creating exciting new roles for pharmacists in general practices, urgent and emergency care and care homes, to independent prescribing and contributions to the development of new medicines. Pharmacists here play a vital role in our unique National Health Service, as the first port of call for patient care, and in the pharmaceutical industry with innovations in drug discovery, design and formulation that are changing the future of healthcare. Pharmacy in Great Britain is constantly evolving, with collaboration from pharmacists across every sector forming the future of pharmacy. Nationwide frameworks for advanced practice have been developed to ensure pharmacists exhibit excellence in all of their roles, with important work being done on the ever-evolving workforce. Attend this session to hear about how Great Britain contributes to pharmacy on a local, national and global level, to identify challenges and opportunities for innovation in pharmacy, and learn from us what we are doing to find the opportunities for growth in a changing world for pharmacists.


08:30 – 09:00                      Arrival and networking

09:00 – 09:10                     

1. Welcome and Introduction

Claire Thompson (Royal Pharmaceutical Society, UK)

09:10 – 09:20

2. Pharmacy careers: Workforce delivery

Bernadette Brown (Cadham Pharmacy Health Centre, UK)

09:20 – 09:30

3. Pharmacy careers: RPS leadership in workforce development/ strategic structures

Peter Kopelman (St. George’s, University of London, UK)

09:30 – 09:40     

4. Pharmacy careers: Innovation in initial education

Nigel Ratcliffe (Keele University, UK)

09:40 – 09:55

5. Pharmacy careers: From student to consultant

Mair Davies (Education, Royal Pharmaceutical Society, UK)

09:55 – 10:10

6. Panel Q&A

10:10 – 10:30                    Coffee/tea break (Hall 1)

10:30 – 10:40

7. From policy to publishing: Influence and impact – RPS leadership in policy and publishing

Karen Baxter (Pharmaceutical Press, Royal Pharmaceutical Society, UK)

10:40 – 10:50

8. From policy to publishing: Influence and impact – Innovation in digital publishing and medicines information

Alina Lourie (Pharmaceutical Press, Royal Pharmaceutical Society, UK)

10:50 – 11:05                   

9. Panel Q & A

11:05 – 11:15                     

10. Drug to patient: Collaboration and scientific                                                                                     

Gavin Halbert (University of Strathclyde, UK)

11:15 – 11:25

11. Drug to patient: Innovation in formulation and drug targeting

Kevin Shakesheff (University of Nottingham, UK)

11:25 – 11:35

12. Drug to patient: Industry and manufacture                                                                                          

Gino Martini (Royal Pharmaceutical Society, UK)

11:35 – 11:45

13. Drug to patient: RPS leadership policy influence

Paul Bennett (Royal Pharmaceutical Society, UK)

11:45 – 11:55

14. Panel Q&A

11:55 – 12:00     

Closing remarks